Latest News about VTRS
Recent news which mentions VTRS
Viatris Phase 1 Asset Divestiture Story: Plans To Sell Certain OTC Products, Women's Healthcare Business & More
October 02, 2023
Tickers
VTRS
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
From Benzinga
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
From Benzinga
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
September 22, 2023
From Benzinga
From Motley Fool
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
September 09, 2023
From Motley Fool
From MarketWatch
From Motley Fool
Stock market bulls are still on top
August 31, 2023
From MarketWatch
From Motley Fool
From MarketWatch
From MarketWatch
From Motley Fool
2 Beaten-Down Dividend Stocks to Buy
August 11, 2023
From Motley Fool
Tickers
VTRS
From Motley Fool
Market bears are on the prowl and stocks are in danger
August 10, 2023
From MarketWatch
Viatris Q2 Earnings Beat Estimates, Multiple Sclerosis Therapy Accepted For FDA Review
August 07, 2023
Tickers
VTRS
From Benzinga
Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday
August 07, 2023
From Benzinga
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
August 04, 2023
Tickers
VTRS
From Motley Fool
From MarketWatch
From MarketWatch
From MarketWatch
Tickers
VTRS
From Motley Fool
Better Pharma Buy: Viatris vs. Pfizer
July 19, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.